The University of Texas MD Anderson Cancer Center.
Moffitt Cancer Center.
J Natl Compr Canc Netw. 2023 Sep;21(9):900-909. doi: 10.6004/jnccn.2023.0046.
The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.
NCCN 乳腺癌筛查与诊断指南为医疗保健提供者提供了一个实用且一致的框架,用于筛查和评估一系列临床表现和乳腺病变。NCCN 乳腺癌筛查与诊断专家组由该领域的多学科专家组成,包括肿瘤内科、妇科肿瘤学、肿瘤外科、内科、家庭医学、预防医学、病理学、诊断和介入放射学以及患者权益代表。NCCN 乳腺癌筛查与诊断专家组至少每年召开一次会议,以审查其机构内审查员提供的新数据和意见,以指导对现有建议的更新。这些 NCCN 指南洞察总结了专家组在最近更新指南筛查建议方面的决策和讨论。